🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Imatinib mesylate may interfere with the growth of tumor cells a...
Status
Completed
Location
Kaiser Franz Josef Hospital
Start Date
2002-03
Trial ID
NCT00039364
Treatments Being Tested
THe primary objective is to estimate the response rate at 6 months to Gleev...
Status
Completed
Location
Indiana University
Start Date
2006-05
Trial ID
NCT01673009
Treatments Being Tested
This study will evaluate the molecular response to high dose Gleevec in new...
Status
Completed
Location
Novartis RIGHT Trial Hotline
Start Date
2003-10
Trial ID
NCT00081926
Treatments Being Tested
The purpose of this study is to determine the effectiveness of two drugs, d...
Status
Completed
Location
Hillman Cancer Center
Start Date
2005-08
Trial ID
NCT00251225
RATIONALE: Drugs used in chemotherapy work in different ways to stop cancer...
Status
Completed
Location
Aurora Presbyterian Hospital
Start Date
1993-05-07
Trial ID
NCT00002514
Treatments Being Tested
In absence of vaccine and medications specifically designed to treat SARS-C...
Status
Unknown
Location
Hospital Universitario de Fuenlabrada
Start Date
2020-05-07
Trial ID
NCT04346147
Treatments Being Tested
This study will evaluate efficacy and safety of nilotinib versus imatinib i...
Status
Completed
Location
Birmingham Hematology and Oncology Associates
Start Date
2009-03
Trial ID
NCT00785785
Treatments Being Tested
This study will evaluate the effect of food on the relative bioavailability...
Status
Completed
Location
Multiple Locations
Start Date
2006-09
Trial ID
NCT00420043
Treatments Being Tested
This study is characterizing the pharmacokinetics of vincristine using two ...
Status
Terminated
Location
Princess Margaret Hospital
Start Date
2010-06
Trial ID
NCT01148134
Research on the mechanism of dasatinib down-regulates the expression of PD-...
Status
Unknown
Location
Department of Hematology,Nanfang Hospital, Southern Medical University
Start Date
2021-06-20
Trial ID
NCT04991532